RxSight Reports Q4 Revenue of $32.61M, Exceeding Expectations
Reports Q4 revenue $32.61M, consensus $32.6M. "Based on our fourth quarter results, we believe that the commercial initiatives implemented in the second half of 2025 are showing early signs of progress," said Ron Kurtz, president and CEO of RxSight. "While there is still more work ahead, full year LAL growth reflected strong adoption as physicians and patients recognize the value of the company's differentiated therapy. Our team remains committed to driving the disciplined execution that supports doctors as they deliver the benefits of high-quality customized vision to their patients."
